At the conclusion of this activity, learners will be able to:
1) Discuss the role of precision medicine in cancer.
2) Describe pre- and post-analytic considerations for solid tumor profiling.
3) Identify insights in caner liquid biopsy.
Honey V. Reddi, PhD, FACMG
All persons in control of content have NO relevant financial relationships to disclose with the exception of the following
|Honey V. Reddi, PhD, FACMF||AstraZeneca||Advisory Board Member|
- 1.00 AMA PRA Category 1 Credit(s)™AMA PRA Category 1 Credit(s)™
- 1.00 Hours of ParticipationHours of Participation credit.